.1 and 11.1. All of these tables may be found online at http://www.ustransplant.org. 
Introduction
Organ donation is vital to the success of transplantation. Its importance has been underscored most recently by the Organ Donation Breakthrough Collaborative, which was initiated by U.S. Department of Health and Human Services Secretary Tommy G. Thompson. The goal of the collaborative is to test and share organ donation best practices, as observed nationally by organ procurement organizations (OPOs) and large donor hospitals in the OPO service area. The collaborative has emphasized that the assessment of performance is given not only by OPO activity but also by a shared responsibility of the hospitals within the service area of the OPO to develop and implement highly effective organ donation systems. To better reflect the joint responsibility shared among these organizations, their collective performance is measured over the donation service area (DSA). DSA is the term used to define the geographical service area designated by the Federal government and assigned to an OPO for recovery of organs from all hospitals in that region. In 2003, the most current year discussed in this report, there were 59 DSAs in the United States.
To adequately assess practices, it is necessary to develop and refine a set of standard metrics of organ donor analysis. These metrics reflect assessments of donor potential, rates of donation, timely notification of deaths to an OPO for evaluation of medical suitability, use of effective request practices and donation rates based upon rates of conversion of potential to actual donors. This report uses all these tools to describe the activity of DSAs and the current state of organ donation in the United States. In the coming months, the collaborative will continue to focus on increasing the number of deceased donors and the donation rate as well as the number of organs transplanted per donor ( Table 1 ). The definitions used in this report to describe the various steps in the organ donation process are provided in Table 2 . The sequence of events, from death to transplant, is illustrated in Figure 1 .
Unless otherwise noted, the statistics in this article are drawn from the reference tables in the 2004 OPTN/SRTR Annual Report. Two companion articles in this report, 'Transplant data: sources, collection and research considerations' and 'Analytical approaches for transplant research, 2004', explain the methods of data collection, organization and analysis that serve as the basis for this article (1, 2) . Additional detail on the methods of analysis employed herein may be found in the reference tables themselves or in the technical notes of the OPTN/SRTR Annual Report, both available online at http://www.ustransplant.org.
The pattern and profile of deceased organ donation
The last decade has seen a steady increase in the number of deceased organ donors, from 5099 donors in 1994 to In ongoing efforts to increase the number of donors, measures continue to be developed to better utilize older donors and donors with pre-existing medical comorbidities. On an organ-specific level, the only formal criteria for such donors are in kidney transplantation, where a subset of donors with a higher risk of graft failure has been designated as expanded criteria donors (ECD). In addition, a steady increase can be seen in the use of organs recovered from donors who sustained cardiac death. Donation after cardiac death (DCD) provided the initial source of organs in the early days of transplantation before brain death was clearly defined. The growth in the number of both ECD and DCD donors has been dramatic ( Figure 3 ). 
Recovery of organs
The changing characteristics of the donor pool appear to have resulted in an increase in the non-recovery of consented organs (Figure 4 ). Non-recovery occurs because of unsuitable characteristics, such as medical history or poor organ function, or following surgical inspection of the organ in the operating room at the time of intended recovery. it relates to a specific organ (e.g. liver), will make it appear that the discard rate of other organs is increasing, since the total number of donors will increase, while utilization of these donors may not be appropriate for other organs.
The accumulation of discarded kidneys over the past decade now exceeds 11 000 ( Figure 5 ). This figure suggests the possibility that further analyses into reasons for non-use might lead to practice changes resulting in improved utilization.
Living versus deceased organ donors
The number of living donors continues to exceed the number of deceased donors, as it has since 2001 ( Figure 6 ). However, it is also noteworthy that the rate of increase in living donors has not been sustained; instead, the number has almost plateaued. 
Relationship of the living kidney donor to the recipient
In 2003, 32% of living kidney donors were either spousal or otherwise unrelated to the recipient ( Figure 8 ). This increase represents a continuing trend, and has been associated with excellent survival (Table 3 ). The adjusted 5-year allograft survival for an unrelated kidney transplant is not different from the survival achieved by the transplant of a kidney from a parent or child of the recipient, regardless of HLA mismatch (SRTR analysis, May 2004). These observations have influenced practice; there is little concern today about the degree of HLA match if a bloodtype and cross-match compatible living donor can be identified, either known or, in some instances, unknown by the recipient. 
Ethnicity and organ donation
There are many factors associated with individual decisions to pursue or not pursue donation; one of the most frequently cited is the effect of race and ethnicity on donation. Examination of the OPTN/SRTR data demonstrates that, over the last decade, the donor pool was derived from all races at rates roughly proportionate to their distribution in National Census data. In 2003, African Americans represented 13% of the U.S. population and 14% of all organ donors. The distribution of kidney, liver and heart donors by race was also proportionate. Organ donation by ethnicity also approximated the distribution in the general population, with the Hispanic/Latino population constituting 13% of all donors and 13% of the U.S. population. Over the past 10 years, there has been a gradual increase in the percentage of non-white and Hispanic/Latino donors (Table 4) . While these data suggest that minority populations donate at a rate proportionate to their representation in the general population, this analysis does not reflect how many donor families were approached regarding donation, and how often consent was obtained. In this context, some studies have revealed a rate of donation significantly lower among minority populations (4, 5) .
A retrospective analysis performed by the Association of Organ Procurement Organizations (AOPO) from 1997 through 2000 provides useful insight regarding the impact of race on approach for donation, consent for donation and actual donation. As shown in Figure 9 , the percentage of potential donor families approached regarding consent ranged from 76% to 86% across all races. Families of white donors were more likely to be approached compared with non-white donors (6).
For whites, consent for donation was granted only 61% of the time it was requested. For non-white donors, this consent rate was dramatically lower. Only 30% of the families of Asian donors granted consent and 34% of the African American families granted consent. The combined effect of these factors is apparent when the organ donation rate is calculated by dividing the number of donors where at least one organ is recovered for the purpose of transplant by the total number of potential donors. Only 49% of white potential organ donors became actual donors. The donation rate is even lower in the minority population, with only 25% of all potential African American organ donors and 23% of all Asian potential donors actually providing organs for transplant (6) . The effect of the lower donation rate in minority populations on the overall donor supply is illustrated in Figure 10 . African American and Asian individuals represented 21% and 4% of all potential organ donors, respectively, but only 12% and 2% of actual organ donors (6).
The reasons for lower donation rates in minority populations may include misinterpretation of religious tenets, distrust of the medical establishment, fear of premature declaration of death if a donor card had been signed and concern among minority donors regarding the relative allocation of organs to minority recipients (7) (8) (9) (10) (11) (12) (13) (14) . Some investigators have suggested that a lack of understanding about the process generates a reluctance to donate, and that this reluctance is hidden under the guise of religious beliefs or mistrust of the medical system (15, 16) . Additionally, specific misconceptions about the process are perhaps more influential in the decision not to donate rather than a generalized lack of knowledge about transplantation and donation (7, 17, 18) .
The lower donation rate in minority populations does not reflect a lack of need within these groups for transplantation. Figure 11 illustrates the relative distribution of race within the U.S. population compared with the kidney, pancreas and kidney-pancreas waiting lists. The representation of African Americans on the kidney transplant waiting list is nearly threefold higher than that found in the general population, undoubtedly reflecting the higher incidence of hypertension and diabetes in this population. Figure 12 demonstrates a similar analysis for the heart and liver waiting lists. Again, all races are represented on both waiting lists, though the percentage of whites on the liver waiting list is slightly higher relative to the percentage of whites in the overall population. Conversely, there exists a higher percentage of African Americans on the heart waiting list. As with the kidney waiting list, this finding may reflect, at least in part, a difference in the incidence of endstage liver and heart disease or a difference in access to care in these populations.
Assessing donor potential
Although the number of organ donors and resulting transplants in the United States is easily tallied, the number of individuals who could become organ donors across the country can only be estimated ( Figure 13 ; SRTR analysis, June 2004). Several estimates of donor potential have relied on retrospective reviews of hospital medical records of deceased patients. The AOPO has spearheaded a multiyear chart review study with submission of data from more Implicit in the AOPO chart review process or in any attempt to study organ donation is the need for the definition of a medically suitable organ donor. Consensus on the definition of what constitutes such a donor is not easily reached, because wide variation exists in the acceptance of organs among transplant centers and regions. Without a consistent definition by which to report data, comparisons across DSAs must be examined in the context of a broader array of measures and information.
In an attempt to quantify the number of medically suitable organ donors, the OPTN currently defines the term eligible death as a patient 70 years old or younger who, prior to death, is reported by a hospital to an OPO, and who is ultimately declared brain-dead according to hospital policy independent of family decision regarding donation or availability of next-of-kin, independent of medical examiner or coroner involvement in case, and independent of local acceptance criteria or transplant center practice.
Furthermore, this patient exhibits no absolute contraindication to organ donation, such as metastatic cancer or seropositivity for human immunodefiency virus. By restricting the pool to ages 70 years and younger who are reported by the hospital to the OPO, donors over the age of 70 years are excluded from this definition, as are patients who are declared brain-dead and meet the criteria but are never reported to the OPO. This definition also excludes patients who never meet brain death criteria, but who might be considered for DCD.
Since 2001, OPOs have been submitting monthly data to the OPTN on the number of referrals (deaths or imminent deaths) received from hospitals and the number of eligible deaths in their service area. These data are combined with OPTN data on total deceased donors recovered and reported by each DSA to the OPTN. Deceased donors comprise 'actual' donors, who meet the criteria of eligible death, and 'additional' donors, who are outside the definition of eligible death, e.g. patients who were over 70 years old or died after cardiac arrest. OPOs were able to see data for their own DSAs on a secure SRTR website for 6 months and encouraged to check and report discrepancies that appeared. In January 2004, DSA-specific data on referrals, eligible deaths, consents for donation, total deceased donor (including both actual and additional donors) and donation rates became publicly available online at www.ustransplant.org. 
Referrals, eligible deaths and actual donors

Differences in procurement and utilization
Although there have been several proposals (Joint Commission on Accreditation of Healthcare Organizations white paper [3] , Crystal City conference [20] and Health and Human Services Collaborative) to encourage best practices in organ donation, wide variations exist in the number of organs recovered and transplanted across regions (3). While DCD organs make up a small fraction of organs recovered for transplant, they appear to be good quality organs. The number of organs transplanted per donor versus the number of organs recovered per donor for DCD is 2.04 versus 2.57. This translates to approximately 79% of organs recovered from DCD donors being transplanted, which compares favorably with non-DCD (89%). Among kidney donors, 82% of DCD organs recovered are transplanted, which is significantly greater than the 62% of recovered kidneys transplanted from ECD ( Table 5 ). The difference in the number of recovered kidneys transplanted between DCD and ECD donors likely represents the better medical condition of DCD donors compared with ECD donors. Nonetheless, despite these observations, as well as increasing experience with DCD kidneys and several reports that support the use of intra-abdominal organs from DCD, relatively few OPOs currently perform DCD recoveries ( 
Donation after cardiac death
Heart
The number of hearts recovered declined from a peak of 2525 in 1994 to 2121 in 2003 ( Figure 15 ). The heart is one of the most highly utilized organs after recovery, with a discard rate of only 1% after procurement. The regional variation of use for this organ is minimal, with only seven DSAs having less than 95% of recovered hearts transplanted. The number of shared hearts across DSAs since 1997 has remained constant, between 30% and 35%. However, after consent, the number of hearts not procured doubled from 1292 in 1994 to 2601 in 2003. This increase in the turndown rate probably reflects a change in number of donors with a CVA as cause of death. Recent reports of hormonal resuscitation to stabilize donors may allow for a further increase in utilization of cardiac donors in the future (21) .
Lung
Lung procurement has remained unchanged in the last decade, with 1694 lungs procured in 1994 compared with 1772 in 2003 ( Figure 15 ). The number of lungs shared across DSAs has remained constant at about 40% for the past 3 years. Similar to the cardiac experience, the decline in the number of lung offers is notable, as non-recovery of consented organs has increased from 6321 in 1994 to 8521 in 2003. Two-thirds of donors were turned down because of poor lung function. Although the mean number of Overall, compared with other abdominal transplants, there is high utility for liver, with only 4% of recovered organs discarded. The majority of organs discarded were because of biopsy results. In addition, 548 consented donors did not undergo procurement, predominantly because of issues pertaining to graft quality. Not surprisingly, the nonprocurement rates were higher among older donors and DCD donors compared with donors <60 years old.
Intestine
Of the many types of transplant procedures, intestinal transplantation is performed least often and only by a small number of centers. Two-thirds of the recovered organs are transplanted outside the DSA in which they were recovered. In 2003, 122 intestines were recovered.
Kidney
The number of kidneys procured has continued to show a slight increase, approximately 2% each year, mirroring the increase in the number of donors each year. Although in recent years the increase in kidney donation appears, in large part, because of increased numbers of older or ECD, the percentage of procured kidneys that are discarded and the frequency of the reasons given for discard have remained essentially unchanged since 1995. Each year, 10-14% of recovered kidneys are discarded. Adverse biopsy result is the reason given for discard for approximately 40% of discarded recovered kidneys. However, the characteristics of a donor kidney biopsy that predict the quality of organ function are not universally accepted (22) (23) (24) (25) (26) . An additional 25% of recovered kidneys are declined based on clinical judgment, with reasons for declining classified as 'organ unsatisfactory' or 'poor organ function/infection'.
Similar to the thoracic experience, the number of kidneys not recovered after consent was obtained has increased each year. Only 469 donor organs were not recovered after consent in 1994 compared with 1053 in 2003. In 1994, only 44% of the non-recovered kidneys were deemed unsatisfactory or had poor organ function; however, in the more recent era, 1999-2003, almost 60% met these criteria.
Pancreas
Pancreas procurement seems to have plateaued in the last few years at approximately 1800 per year from 2000 to 2003 ( Figure 16 ). The discard rate is almost twice that of renal organs, approximately 17% of recovered pancreata. As with kidneys, the majority of the discards result from concerns about poor quality. Among recovered pancreata that were discarded in 2003, unavailability of the recipients was the reason for discard in 14% of cases. An additional 10% of pancreata were not recovered after consent, because recipients were unavailable (SRTR analysis, May 2004). 
Expanded criteria kidney donors
Potential for defining expanded criteria liver donors
There are several deterrents that prevent procurement and transplant of livers from expanded donors. The most limiting factor is the lack of objective criteria, e.g. cardiac anatomy and function for hearts or oxygen challenge in lungs, that can be uniformly applied. The decision to use a particular donor liver continues to be subjective and is best described by Heaton and colleagues, who note that the decision is not proven right until after transplant (27) . These decisions are made given the reality that no reliable support exists for a failed liver and that even the best clinical judgment may result in the need for retransplant of the recipient.
Expanded criteria for kidney donors were developed based on lower graft survival in certain categories. Similarly, criteria could be developed for liver donors to allow for improved use of liver grafts and better information for recipients. In most instances, the decision to procure and transplant a graft is based on a constellation of clinical data. (29) . In a more recent report (2001), Busquets et al. observed that liver allografts from donors older than 70 years had a 6-month survival of 56%; survival at 54 months was 25% (30) . DebRoy et al. have demonstrated an important interaction between older donor age and prolonged cold ischemia time, such that the combination is associated with particularly poor outcomes (31) .
Another likely criterion would be the degree of steatosis. The escalating incidence of obesity among the general population suggests that steatosis could be an increasing concern in evaluating donor livers. The reported incidence is estimated to be between 9% and 26%. Steatotic livers have been associated with an increased incidence of poor graft function and primary non-function. There is consensus that grafts with greater than 60% fat should not be used for transplant (32) . In a timematched control study, Marsman et al. have shown that grafts with moderate steatosis up to 30% have decreased graft survival at 4 months and also decreased patient survival at 2 years (33) . Recent studies report no increased risk from using grafts with microvesicular steatosis (34) . However, the interpretation of fat on biopsy is subject to the judgment of the local pathologist and transplant surgeon.
Other widely accepted clinical criteria that increase risk of non-function include ICU stay > 5 days, particularly without nutritional support; hypernatremia with serum sodium >160 mEq/dL; hypoxia; vasopressor use with an increase in liver chemistries, and prolonged cold ischemia time.
Cause of death does not appear to be a predictor of nonfunction among liver donors.
In addition to these donor-specific criteria, the decision whether to use a liver from an extended donor must take into account the severity of illness of the intended recipient. Such grafts placed into severely ill recipients provide a recipe for a dismal outcome, suggesting that these grafts should be directed away from recipients with high model for end-stage liver disease (MELD) scores, perhaps greater than 30 (35) . On the other end of the illness scale, recent data presented by Merion et al. suggest that those candidates with a MELD score <15 had a higher risk of mortality with transplant than did medically managed patients on the waiting list (36) . Clearly, the use of an extended donor liver in these healthier candidates is not in the best interest of such candidates. It may be reasonable to offer such livers first to recipients with a MELD score between 15 and 30, after obtaining informed consent. As more data are collected, these criteria may need to be modified.
Summary
This article provides an overview of organ donation trends in the United States. Recently, the number of deceased donor organs recovered per year has been increasing gradually. Non-traditional donor sources have experienced a much larger rate of increase; the number of ECD kidney donors has increased 8% and the number of DCD donors has increased 43% during the past year ( Figure 3) . The relative percentages of Hispanic/Latino and African American donors have trended upward as well. Although the number of living donors continues to exceed the number of deceased donors, the rate of growth from this source was smaller in 2003 ( Figure 6 ). Unrelated living kidney donation has been shown to achieve excellent graft survival. Currently, unrelated donors make up over 30% of all living kidney donors.
The number of potential donors in the United States is estimated to be between 10 500 and 13 800 (6), which is consistent with the number of eligible deaths reported by DSAs nationwide. Despite the fact that the total number of eligible deaths remained flat in 2003, there exists a large amount of variability in donor potential at the DSA level. Donation rates among DSAs also vary considerablyalthough these rates currently do not account for DCD or donors above 70 years of age.
